Effective Jan. 1, updated policies for telehealth, telemedicine, and virtual care.
See monthly clinical practice and business updates.
Effective Jan. 1, Group Health will make a change in our CD Residential Review Process. We will follow our actual review process, which states that we will review all CD Residential Requests for Treatment on the next business day and give a decision within 24 hours.
Effective Jan. 16, a new site of service prior authorization is required for some drugs.
Effective Jan. 1, Group Health will reimburse at the in-network benefit level for services rendered to members by in-network providers.
Effective Jan. 1, will reimburse at the in-network benefit level for services rendered to commercial members by in-network providers.
Latest pharmacy news from Group Health for providers.
See Clinical Pearls recommendations you can integrate into your practice.
Patient Referrals into Seattle Area
When referring Group Health patients to the Seattle area for care, we ask all referring providers to explore the clinical excellence available at Group Health Medical Centers and encourage you to select Group Health first. See Provider Update, page 4.
Effective Dec. 1, prior authorization is required for BRCA and Lynch Syndrome testing.
Quick reference guide of HEDIS measures for pediatric and adolescents includes coding information and tools for improving performance.
Non-Medicare Drug List updated Nov. 22.
Group Health's quick reference guide of common HEDIS measures includes newly issued statin measures for patients with cardiovascular disease and diabetes.
See what's offered, which services require preauthorization, and get information about claims submissions.
Updates to our guidelines, services, provider manual, and other important information.
For questions about your existing account, call OHP technical support at 1-800-973-4797.
Don't have an account? Visit OneHealthPort for more information.
Change to Your Practice?
Group Health Appointment Access Standards